Sodium-glucose cotransporter 2 inhibitor may not prevent atrial fibrillation in patients with heart failure: a systematic review

BACKGROUND: Atrial fibrillation (AF) and heart failure (HF) frequently coexist because of their similar pathological basis. However, whether sodium-glucose cotransporter 2 inhibitor (SGLT2i), a novel class of anti-HF medication, decreases the risk of AF in HF patients remains unclear. OBJECTIVES: Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Ouyang, Xiaolan, Wang, Jiafu, Chen, Qian, Peng, Long, Li, Suhua, Tang, Xixiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10210497/
https://www.ncbi.nlm.nih.gov/pubmed/37226247
http://dx.doi.org/10.1186/s12933-023-01860-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10210497/
https://www.ncbi.nlm.nih.gov/pubmed/37226247
http://dx.doi.org/10.1186/s12933-023-01860-1

Ejemplares similares